Office of Research & Development |
|
Project Number: | I01BX002301-09 |
Title: | Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival |
Principal Investigator: | Ann Richmond |
Location: | Nashville, TN |
Congressional District Code: | 5 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | January 2022 - December 2025 |
FY 2022 Funding Amount: | $173,750 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |